T-Track® SARS-CoV-2

RT-qPCR-based assay for the detection of T cell reactivity against SARS-CoV-2 antigens.

OurMikrogen T-Track® SARS-CoV-2 is another test of the new RT-qPCR-based assays of our T-Cell Diagnostics product line for the detection of T-cell mediated immunoreactivity. The test is based on RT-qPCR and thus achieves excellent sensitivity. The use of recombinant antigens and two different markers as read-out sets it apart from the commonly used SARS-CoV-2 specific T-cell tests.


The T-Track® SARS-CoV-2 comprises two diagnostic kits:
1. T-Track® SARS-CoV-2 Stimulation includes stimulation of 2 ml of heparinized whole blood with S1 and NP antigens followed by RNA stabilization.
2. T-Track® SARS-CoV-2 Quant PCR includes the reagents required to perform multiplex RT-qPCR and the evaluation software supplied separately.

Products

Kit 1 from 2
Reagents for the analysis of 8 patient samples
Article no.: 11001006 Request
Kit 2 von 2
34 Reactions
Article no.: 11001007 Request

Advantages

  • Detection of T cell reactivity against the SARS-CoV-2 antigens: S1 (spike protein subunit) and NP (nucleocapsid protein).
  • Patented technology with innovative marker combination (IFNG, CXCL10)
  • Stimulation in whole blood (2 ml)
  • Maximum flexibility and efficiency due to the ability to collect patient samples at multiple points in the workflow
  • Easy handling, standardized and partially automated execution
  • Software-based analysis

Safe and reliable

Highly sensitive and standardized instrument for immune monitoring

T-cell diagnostics

To support individual therapy decisions

IVD

IVD

RT-qPCR-based in vitro diagnostic agent